I TUOI DATI
I TUOI ORDINI
N. prodotti: 0
Totale ordine: € 0,00
I TUOI ABBONAMENTI
I TUOI ARTICOLI
THE JOURNAL OF CARDIOVASCULAR SURGERY
Rivista di Chirurgia Cardiaca, Vascolare e Toracica
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632
ORIGINAL ARTICLES CARDIAC PAPERS
The Journal of Cardiovascular Surgery 2001 February;42(1):1-7
Effects of “Hot shot” on recovery after hypothermic ischemia in neonatal lamb heart
Nomura F., Forbess J. M., Mayer E. Jr.
From the Department of Cardiovascular Surgery Children’s Hospital, Boston The Department of Surgery Harvard Medical School, Boston, USA
Background. Terminal warm blood cardioplegia, ''Hot shot'', is the method for providing an energy replenishment and/or early recovery of aerobic metabolism without electromechanical activity at initial reperfusion. The mechanism of beneficial effects of this “Hot Shot” is multifactorial. This study was designed to assess the effects of terminal warm blood cardioplegia by comparing with oxygenated terminal warm crystalloid cardioplegia.
Methods. In Group HS-B, n=8 (oxygenated blood; 37°C, Ht: 20%, K+ 20 mEq/l, pH 7.237, PO2 219 mmHg) and in Group HS-C, n=8 (bloodless oxygenated (5% CO2+95%O2) crystalloid, 37°C, K+ 20 mEq/l, pH 7.435, PO2 624 mmHg), terminal warm cardioplegia (20 ml/kg for 5 minutes) was studied in the isolated blood perfused neonatal lamb heart following 2 hr of cardioplegic ischemia. Another eight hearts served as control without any kind of terminal cardioplegia. After 60 min of reperfusion, LV function was measured. Coronary blood flow (CBF), oxygen content, and oxygen consumption (MVO2) were measured and the oxygen extraction ratio was calculated in Group HS-B and HS-C during terminal cardioplegia and/or reperfusion. Results are given as % recovery of preischemic values.
Results. HS-B as well as HS-C groups showed better functional recovery in maximum developed pressure (DP: 78.0±8.3 in HS-B vs 65.2±9.2%; p=0.018), maximum dp/dt (67.3±6.2 in HS-B, 65.3±7.4 in HS-C vs 55.8±5.0%; p=0.003, p=0.02), DP V10 (87.1±8.5 in HS-B vs 67.2±9.9%; p=0.0001), and peak dp/dt V10 (76.4±7.6 in HS-B, 69.8±8.1 in HS-C vs 58.6±6.9 %; p=0.0001) than the control group. Between the HS-B and HS-C groups, HS-B showed better functional recovery in terms of DP V10 (p=0.01). Oxygen delivery of terminal cardioplegia was almost four times higher in HS-B group (90.4±17.7 vs 18.7±1.1 mcl/ml), contrarily, HS-C group showed four times higher oxygen extraction ratio compared to HS-B group (0.78±0.06 vs 0.18±0.11), thus oxygen consumption during hot shot was maintained at the same level in both groups. CBF in the control group was lower than that in the other groups at 60 min of reperfusion.
Conclusions. Reperfusion with both terminal warm cardioplegia including blood and oxygenated crystalloid cardioplegia resulted in better recovery of function and higher levels of CBF with slightly better function in terminal warm blood cardioplegia.